Skip to content

Francis P. Baco, MD

NPI 1588615058ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Guaynabo, PR

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Guaynabo, Puerto Rico, licensed in PR and MA, with an NPI issued in May 2006. Part D covered 43 prescriptions written in 2024, 65% of them generic. Novo Nordisk Inc was the largest of 2 companies reporting payments in 2024, $192.08 in all, mostly food and beverage.

Overview

NPI1588615058
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMay 12, 2006
Last updated in NPPESSep 30, 2008

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (PR)

Part D prescriptions in 2024

Prescriptions (claims)43 · 50 30-day fills
Total drug cost$3,404
Generic share65% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$192.08 · 3 payments from 2 companies

Top paying companies in 2024

CompanyAmountPayments
Novo Nordisk Inc$116.822
Corcept Therapeutics$75.261

What the 2024 payments were for

  • Food and Beverage$192.08 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Guaynabo

All endocrinologists in Puerto Rico